Skip to content
Screener

QuidelOrtho Corporation QDEL Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

OraSure Technologies logo
OraSure TechnologiesOSUR
$25M
Revvity logo
RevvityRVTY
$1M0.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Agilent Technologies logo
Agilent TechnologiesA
Veracyte logo
VeracyteVCYT
Labcorp Holdings logo
Labcorp HoldingsLH

Other financials

Income statement

See full
Revenue$630.9M+2.8%
Gross profit$272.9M-0.7%
Operating income-$21.8M+87.9%
Net income-$92.9M+63.6%
EPS (diluted)-$1.36+63.9%

Balance sheet

See full
Cash & equivalents$123.4M-18.7%
Total debt$3.4B+3.0%
Total equity$1.8B-36.4%
Total assets$5.7B-10.4%

Cash flow

See full
Operating cash flow-$110.6M
CapEx$25.5M-32.0%
Free cash flow-$136.1M-61.4%

Valuation

See full
Market cap$942.91M-41.3%
Enterprise value$4.25B-11.2%
P/S0.4×-0.2×

Profitability

See full
Gross margin44.6%-2.7pp
Operating margin-30.8%-49.9pp
Net margin-39.2%-168pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-45.9%-94.9pp
Debt / equity1.9×+0.7×
Current ratio1.4×+0.3×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The source filing: QuidelOrtho Corporation’s 10-Q, filed August 7, 2026.

Filed
Aug 6, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0001906324-26-000033
Line itemJune 28, 2026December 28, 2025
Total liabilities3,940.43,848.8
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock, $0.001 par value per share; 5.0 shares authorized; none issued or outstanding at June 28, 2026 and December 28, 2025
Common stock, $0.001 par value per share; 126.2 shares authorized; 68.3 and 67.9 shares issued and outstanding at June 28, 2026 and December 28, 2025, respectively0.10.1
Additional paid-in capital2,954.72,931.8
Accumulated other comprehensive income (loss)0.8(15.4)
Accumulated deficit(1,180.7)(996.0)

Item 1. Financial Statements (unaudited)

FAQ

What is QuidelOrtho Corporation's preferred stock, shares authorized?
QuidelOrtho Corporation (QDEL) reported preferred stock, shares authorized of $5M in Q2 2026.
How has QuidelOrtho Corporation's preferred stock, shares authorized changed year-over-year?
QuidelOrtho Corporation's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
What is the long-term trend for QuidelOrtho Corporation's preferred stock, shares authorized?
Over 2 years (2023 to 2025), QuidelOrtho Corporation's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.
What does preferred stock, shares authorized mean?
Preferred Stock, Shares Authorized

Ask your AI about QuidelOrtho Corporation's preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude